Bayer AG annual current ratio
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Current Ratio Growth & History (BAYN)
Bayer AG's current ratio was 1.01 for fiscal 2025.
View full Bayer AG company overviewBayer AG annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.01 | −0.18 | −15.10% |
| 2024 | 2024-12-31 | 1.19 | −0.09 | −6.69% |
| 2023 | 2023-12-31 | 1.27 | 0.20 | +18.46% |
| 2022 | 2022-12-31 | 1.08 | −0.03 | −2.86% |
| 2021 | 2021-12-31 | 1.11 | 0.14 | +14.12% |
| 2020 | 2020-12-31 | 0.97 | −0.43 | −30.77% |
| 2019 | 2019-12-31 | 1.40 | 0.05 | +3.48% |
| 2018 | 2018-12-31 | 1.36 | −0.86 | −38.74% |
| 2017 | 2017-12-31 | 2.21 | 0.57 | +34.70% |
| 2016 | 2016-12-31 | 1.64 | 0.24 | +17.08% |
| 2015 | 2015-12-31 | 1.40 | −0.03 | −2.15% |
| 2014 | 2014-12-31 | 1.43 | 0.08 | +5.66% |
| 2013 | 2013-12-31 | 1.36 | −0.09 | −6.38% |
| 2012 | 2012-12-31 | 1.45 | −0.05 | −3.29% |
| 2011 | 2011-12-31 | 1.50 | −0.19 | −11.35% |
| 2010 | 2010-12-31 | 1.69 | — | — |
Bayer AG quarterly current ratio
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.04 | −0.09 | −8.01% |
| Q1 2026 | 2026-03-31 | 1.06 | — | — |
| Q4 2025 | 2025-12-31 | 1.01 | — | — |
| Q3 2025 | 2025-09-30 | 1.14 | — | — |
| Q2 2025 | 2025-06-30 | 1.13 | — | — |
Bayer AG current ratio trends
Over the last five fiscal years, Bayer AG's current ratio increased from 0.97 to 1.01, a change of 0.04. The latest reported quarter, Q2 2026, shows 1.04.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as reported current assets divided by reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
